Clinical Trial Update: A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating ChAdOx1 and MVA vaccines targeting MAGE-A3 and NY-ESO-1 for non-small cell lung cancer and esophageal squamous cell carcinoma has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• ChAdOx1-MAGE-A3 vaccine (ChAdOx1-MAGE-A3)
• MVA-NY-ESO-1 vaccine (MVA-NY-ESO-1)

Snippet

Sponsor: Cancer Research UK | Conditions: Non-small Cell Lung Cancer (NSCLC), Squamous Oesophageal Cancer | Phase 1, Phase 2 | Status: SUSPENDED